Literature DB >> 24099043

Mass spectral profiling of glycosaminoglycans from histological tissue surfaces.

Chun Shao1, Xiaofeng Shi, Joanna J Phillips, Joseph Zaia.   

Abstract

Glycosaminoglycans (GAGs) are found in intracellular granules, cell surfaces, and extracellular matrices in a spatially and temporally regulated fashion, constituting the environment for cells to interact, migrate, and proliferate. Through binding with a great number of proteins, GAGs regulate many facets of biological processes from embryonic development to normal physiological functions. GAGs have been shown to be involved in pathologic changes and immunological responses including cancer metastasis and inflammation. Past analyses of GAGs have focused on cell lines, body fluids, and relatively large tissue samples. Structures determined from such samples reflect the heterogeneity of the cell types present. To gain an understanding of the roles played by GAG expression during pathogenesis, it is very important to be able to detect and profile GAGs at the histological scale so as to minimize cell heterogeneity to potentially inform diagnosis and prognosis. Heparan sulfate (HS) belongs to one major class of GAGs, characterized by dramatic structural heterogeneity and complexity. To demonstrate feasibility of analysis of HS, 15 μm frozen bovine brain stem, cortex, and cerebellum tissue sections were washed with a series of solvent solutions to remove lipids before applying heparin lyases I, II, and III on the tissue surfaces within 5 mm × 5 mm digestion spots. The digested HS disaccharides were extracted from tissue surfaces and then analyzed by using size exclusion chromatography/mass spectrometry (SEC-MS). The results from bovine brain stem, cortex, and cerebellum demonstrated the reproducibility and reliability of our profiling method. We applied our method to detect HS from human astrocytoma (WHO grade II) and glioblastoma (GBM, WHO grade IV) frozen slides. Higher HS abundances and lower average sulfation level of HS were detected in glioblastoma (GBM, WHO grade IV) slides compared to astrocytoma (WHO grade II) slides.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24099043      PMCID: PMC3872031          DOI: 10.1021/ac402517s

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  32 in total

Review 1.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate.

Authors:  Kazuyuki Sugahara; Tadahisa Mikami; Toru Uyama; Souhei Mizuguchi; Kazuya Nomura; Hiroshi Kitagawa
Journal:  Curr Opin Struct Biol       Date:  2003-10       Impact factor: 6.809

Review 3.  Roles of heparan-sulphate glycosaminoglycans in cancer.

Authors:  Ram Sasisekharan; Zachary Shriver; Ganesh Venkataraman; Uma Narayanasami
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

4.  A structural analysis of glycosaminoglycans from lethal and nonlethal breast cancer tissues: toward a novel class of theragnostics for personalized medicine in oncology?

Authors:  Amanda Weyers; Bo Yang; Dae Sung Yoon; Jong-Hwan Park; Fuming Zhang; Kyung Bok Lee; Robert J Linhardt
Journal:  OMICS       Date:  2012-03

5.  Quantification of hyaluronan and chondroitin/dermatan sulfates in the tissue sections on glass slides.

Authors:  I Koshiishi; E Horikoshi; T Imanari
Journal:  Anal Biochem       Date:  1999-02-01       Impact factor: 3.365

Review 6.  Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans.

Authors:  Atsuko Yoneda; Maria E Lendorf; John R Couchman; Hinke A B Multhaupt
Journal:  J Histochem Cytochem       Date:  2012-01       Impact factor: 2.479

7.  Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma.

Authors:  Joanna J Phillips; Emmanuelle Huillard; Aaron E Robinson; Anna Ward; David H Lum; Mei-Yin Polley; Steven D Rosen; David H Rowitch; Zena Werb
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

8.  Domain structure of heparan sulfates from bovine organs.

Authors:  M Maccarana; Y Sakura; A Tawada; K Yoshida; U Lindahl
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

9.  Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma.

Authors:  Martin A Thelin; Katrin J Svensson; Xiaofeng Shi; Mariam Bagher; Jakob Axelsson; Anna Isinger-Ekstrand; Toin H van Kuppevelt; Jan Johansson; Mef Nilbert; Joseph Zaia; Mattias Belting; Marco Maccarana; Anders Malmström
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

10.  Structural characteristics of oversulfated chondroitin/dermatan sulfates in the fibrous lesions of the liver with cirrhosis.

Authors:  I Koshiishi; M Takenouchi; T Imanari
Journal:  Arch Biochem Biophys       Date:  1999-10-15       Impact factor: 4.013

View more
  21 in total

1.  Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.

Authors:  Vy M Tran; Anna Wade; Andrew McKinney; Katharine Chen; Olle R Lindberg; Jane R Engler; Anders I Persson; Joanna J Phillips
Journal:  Mol Cancer Res       Date:  2017-08-04       Impact factor: 5.852

Review 2.  Glycosylation alterations in lung and brain cancer.

Authors:  Hassan Lemjabbar-Alaoui; Andrew McKinney; Yi-Wei Yang; Vy M Tran; Joanna J Phillips
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

3.  Analysis of Total Human Urinary Glycosaminoglycan Disaccharides by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Xiaojun Sun; Lingyun Li; Katherine H Overdier; Lee Anne Ammons; Ivor S Douglas; Clay Cothren Burlew; Fuming Zhang; Eric P Schmidt; Lianli Chi; Robert J Linhardt
Journal:  Anal Chem       Date:  2015-06-02       Impact factor: 6.986

Review 4.  Recent Advances in the Analysis of Complex Glycoproteins.

Authors:  Stefan Gaunitz; Gabe Nagy; Nicola L B Pohl; Milos V Novotny
Journal:  Anal Chem       Date:  2016-11-23       Impact factor: 6.986

Review 5.  Glycosaminoglycanomics: where we are.

Authors:  Sylvie Ricard-Blum; Frédérique Lisacek
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

Review 6.  Proteomics, Glycomics, and Glycoproteomics of Matrisome Molecules.

Authors:  Rekha Raghunathan; Manveen K Sethi; Joshua A Klein; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-08-30       Impact factor: 5.911

7.  Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.

Authors:  Galina M Kazanskaya; Alexandra Y Tsidulko; Alexander M Volkov; Roman S Kiselev; Anastasia V Suhovskih; Vyacheslav V Kobozev; Alexei S Gaytan; Svetlana V Aidagulova; Alexei L Krivoshapkin; Elvira V Grigorieva
Journal:  Histochem Cell Biol       Date:  2018-01-10       Impact factor: 4.304

8.  Rapid Differentiation of Chondroitin Sulfate Isomers by Gas-phase Hydrogen-deuterium Exchange.

Authors:  Kimberly M Alonge; Rick Harkewicz; Miklos Guttman
Journal:  Curr Mol Med       Date:  2020       Impact factor: 2.222

9.  Serial in-solution digestion protocol for mass spectrometry-based glycomics and proteomics analysis.

Authors:  Manveen K Sethi; Margaret Downs; Joseph Zaia
Journal:  Mol Omics       Date:  2020-04-20

10.  Workflow for combined proteomics and glycomics profiling from histological tissues.

Authors:  Lilla Turiák; Chun Shao; Le Meng; Kshitij Khatri; Nancy Leymarie; Qi Wang; Harry Pantazopoulos; Deborah R Leon; Joseph Zaia
Journal:  Anal Chem       Date:  2014-09-24       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.